Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05527392 · ClinicalTrials.gov registry record · NA
Virtual Health Insurance Navigation Pilot Program for Childhood Survivors (HINTII)
A NA study of Childhood Cancer Survivors, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 529
- Enrollment target
- 1
- Study location
NCT05527392: Active NA study of Childhood Cancer Survivors, sponsored by Massachusetts General Hospital.
NCT05527392 is a NA study of Childhood Cancer Survivors that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 529 participants, below the 908-participant average among 6 other Childhood Cancer Survivors trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05527392, a NA study of Childhood Cancer Survivors, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 529 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators are conducting a Type I hybrid effectiveness-implementation trial to assess the effectiveness of HINT-S (synchronous) compared to enhanced usual care (EUC) in promoting health insurance literacy, thus reducing worry, unmet health care needs, and financial consequences due to medical costs to improve care and long-term outcomes of childhood cancer survivors. The investigators will also compare HINT-S to HINT-A (asynchronous), a prerecorded, asynchronous version of the 5 HINT-S navigator sessions.
Primary Outcome
Change in Health Insurance Literacy, measured with the validated survey (Health Insurance Literacy scale; HIL), will be compared between groups. The HIL is a 16-item measure of participants' self-reported confidence in understanding of terms (e.g., deductible, co-payments, co-insurance) and confidence in knowing how to do health insurance-related activity (e.g. figuring out co-payments, finding an in-network doctor). Items are rated on a 4-point Likert scale with a total scale score ranging from
Conditions Studied
Interventions
- BEHAVIORAL Health Insurance Navigation Tools Program
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 529 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
What the registry record for NCT05527392 still lists
NCT05527392 is an interventional study that assigns participants to a tested intervention. The registered 529 participants enrollment target is mid-sized for trials with a published cap, below the 908-participant average among 6 other Childhood Cancer Survivors trials with a reported enrollment target (42% lower).
The record links to 1 condition, with Childhood Cancer Survivors appearing as the primary indexed condition, and to 1 intervention - of which Health Insurance Navigation Tools Program is the first listed.
NCT05527392 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05527392 about?
NCT05527392 is a clinical study titled "Virtual Health Insurance Navigation Pilot Program for Childhood Survivors (HINTII)". The investigators are conducting a Type I hybrid effectiveness-implementation trial to assess the effectiveness of HINT-S (synchronous) compared to enhanced usual care (EUC) in promoting health insurance literacy, thus reducing worry, unmet health care needs, and financial consequences due to medica...
What is the current status of trial NCT05527392?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 529 participants. The study started on 2023-05-01. Estimated completion is 2027-04-01.
What conditions does trial NCT05527392 study?
This clinical trial studies the following conditions: Childhood Cancer Survivors.
What interventions are being tested in trial NCT05527392?
The interventions under investigation include: Health Insurance Navigation Tools Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT05527392?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05527392 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Cancer Survivors
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Proof-of-Concept Testing of the Cardiovascular Health Equity Through Food (CHEF) Intervention in Childhood Cancer Survivors
RECRUITING · NA
-
A Study of Time-Restricted Eating in Childhood Cancer Survivors
RECRUITING · NA
-
Overnight Fasting After Completion of Therapy: The OnFACT Study
ACTIVE NOT RECRUITING · NA
-
Impact of Exercise Intensity on Cardiac Health in Young Adult Survivors of Childhood Cancer: The PULSE Trial
ACTIVE NOT RECRUITING · NA
-
Developing a Health Insurance Navigation Program for Survivors of Childhood Cancer
COMPLETED · NA
-
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06646276 · 530 participants · Phase 3
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
- NCT06703476 · 530 participants · Phase 3
A Study of Surgical Techniques During Cystectomy
- NCT06880744 · 530 participants · Phase 3
A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
- NCT07138040 · 530 participants · NA
Re-Engaging AYA Survivors in Cancer-Related Healthcare
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI